http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2460535-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ea17ba87480b776cce77451f86b25bb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B60S3-063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4741
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-28
filingDate 2009-01-08^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-09-10^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b42d38654d30b440cfe781c3bb1be6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adb8cda9773abae916ab1855e3f84706
publicationDate 2012-09-10^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2460535-C2
titleOfInvention Compositions for mucositis induced by antitumour or immunosuppressive therapy
abstract FIELD: medicine. n SUBSTANCE: invention refers to a pharmaceutical composition, particularly a composition for treating and/or preventing mucositis. The composition containing an effective amount of sanguinarine or chelerythrine in the form of a luteic acid salt mixed with appropriate carriers and/or excipients for treating and/or preventing mucositis. The chelerythrine and luteic acid salt. The sanguinarine and luteic acid salt. The use of sanguinarine or chelerythrine in the form of their lutec acid salts for preparing drugs for treating and/or preventing mucositis. n EFFECT: composition described above of sanguinarine or chelerythrine in the form of the lutec acid salts is effective for treating and/or preventing mucositis. n 10 cl, 8 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2762754-C2
priorityDate 2008-01-11^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006063716-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0565495-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007047003-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID56857
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID945
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID56857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431905786
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5319108
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508891
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1043
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415970532
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5154
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID2371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413823327
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453559758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2179
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID165
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521161
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID457831
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID308558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11074431
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154082691
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID996
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID308558

Showing number of triples: 1 to 51 of 51.